A
Andy Kolb
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
Sep 26, 2026
The Las Vegas Public Affairs Show September 26, 2026
H
30:03Heather ValeHOST
So what's the new way to measure progress in blood cancer that Blood Cancer United recently introduced?
A
30:10Andy KolbGUEST
You know, when we talk about progress in cancer, we often talk about mortality rates, essentially the number of people that die from cancer each year.
A
30:20Andy KolbGUEST
And the great news is that for more than 35 years, the mortality rates in the United States have been going down.
A
30:41Andy KolbGUEST
The challenge is that while those strategies are very effective and have driven incredible reductions in mortality rates, They're not effective for all cancers.
H
31:37Heather ValeHOST
So clearly there's been a lot of progress, but where are the biggest gaps and challenges still facing patients, researchers, and advocates?